Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study by Ahmadi-Abhari, Seyed-Ali et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC Psychiatry
Open Access Research article
Risk factors of thyroid abnormalities in bipolar patients receiving 
lithium: a case control study
Seyed-Ali Ahmadi-Abhari1, Padideh Ghaeli1, Fanak Fahimi*2, 
Fatemeh Esfahanian3, Hasan Farsam4, Ahmad Reza Dehpour5, 
Issa Jahanzad6, Zinat-Nadya Hatmi7 and Simin Dashti1
Address: 1Department of Psychiatry, Roozbeh Academic and Referral Psychiatric Center, 2Clinical Pharmacy unit, School of Pharmacy, Shahid 
Beheshti University of Medical Sciences, 3Department of Endocrinology, Tehran University of Medical Sciences, Tehran, Iran, 4Department of 
Medicinal Chemistry, Tehran University of Medical Sciences, Tehran, Iran, 5Department of Pharmacology, Tehran University of Medical Sciences, 
Tehran, Iran, 6Department of Pathology, Tehran University of Medical Sciences, Tehran, Iran and 7Department of Epidemiology, Tehran University 
of Medical Sciences, Tehran, Iran
Email: Seyed-Ali Ahmadi-Abhari - ahmadiab@sina.tums.ac.ir; Padideh Ghaeli - mmppg@yahoo.com; Fanak Fahimi* - riazifahimi@yahoo.com; 
Fatemeh Esfahanian - f_esfahanian@yahoo.com; Hasan Farsam - farsam@ams.ac.ir; Ahmad Reza Dehpour - Dehpour@medscape.com; 
Issa Jahanzad - jahanzad@sina.tums.ac.ir; Zinat-Nadya Hatmi - hatmizn@sina.tums.ac.ir; Simin Dashti - dashtikhalili@yahoo.com
* Corresponding author    
Bipolargoiterhypothyroidismlithiumlithium ratioside effect
Abstract
Background: Lithium-induced thyroid abnormalities have been documented in many studies.
They may occur despite normal plasma lithium levels. The objectives of this study were: 1) to
determine possible relationship between lithium ratio, defined as erythrocyte lithium
concentrations divided by plasma lithium concentrations, and thyroid abnormalities in bipolar
patients receiving lithium and 2) to find other possible risk factors for developing thyroid
abnormalities in the subjects.
Methods: Sixty-eight bipolar patients receiving lithium therapy were enrolled in a cross-sectional
evaluation of thyroid function test and thyroid size. Patients were divided into two groups based
on their thyroid function tests and thyroid sizes. Erythrocyte and plasma lithium concentrations
were determined by atomic absorption spectrometry for each patient. Lithium ratio was then
calculated.
Results: No significant differences were found between age, positive family history of affective
disorder, plasma lithium concentration, erythrocyte lithium concentration, and lithium ratio
comparing the two groups. Thyroid abnormalities was significantly higher in women than in men (p
< 0.05).
Conclusions: Lithium ratio does not appear to have a predictive role for thyroidal side effects of
lithium therapy. Female gender was the main risk factor. We suggest more frequent thyroid
evaluation of bipolar women who are treated with lithium.
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Background
Lithium therapy is an established treatment in patients
with bipolar disorders. This agent has a narrow therapeu-
tic window. Additionally, lithium is known to cause alter-
ations in various organ functions, thus it merits a regular
monitoring. Among these, alteration in thyroid status in-
duced by lithium treatment is important in the clinical
evaluation of neuropsychiatric effects [1] including fa-
tigue, memory impairment, and anhedonia.
The antithyroid effects of lithium were first observed in
patients who received lithium carbonate and developed
hypothyroidism and goiter. It was subsequently recog-
nized that lithium increases intrathyroidal iodine content,
inhibits the coupling of iodothyrosine residues to form
iodothyronines [2–4] and prevents secretion of T4 and T3
[3–5]. The use of plasma level alone for monitoring could
be misleading since the above side effects may occur even
when lithium plasma levels are within the normal range.
It should be noted that in many respects erythrocyte mem-
brane is similar to nerve cell and possibly some other
cells. Therefore, erythrocytes have been useful for studying
intracellular lithium ion, particularly due to its easy avail-
ability [6]. Lithium ratio (LR), the ratio of erythrocyte lith-
ium concentration (ELC) to plasma lithium
concentration (PLC), has been suggested for studying lith-
ium side effects and may be a better indicator of toxicity
than PLC [7,8].
To our knowledge, the relationship between LR and thy-
roid abnormalities in bipolar patients has not been stud-
ied. We performed this study to determine if LR may have
a better correlation with lithium-induced thyroid abnor-
malities than PLC. This would result in fewer thyroid
function tests (TFT), physical examinations and conse-
quently reduce the cost of thyroid monitoring.
Since plasma lithium concentrations are being measured
in patients receiving lithium, it would be easy to measure
ELC simultaneously.
The study was designed to look at any possible relation-
ship between lithium ratio (LR) and thyroid side effects.
Also other possible risk factors for developing thyroid ab-
normalities were investigated.
Methods
Patient selection
Patients with bipolar disorder, admitted at Roozbeh Men-
tal Health Hospital, who did not receive any drug(s) af-
fecting thyroid or TFT were enrolled in the study. None of
the subjects had a history of thyroid disorder before his/
her first exposure to lithium. All the patients received
equally similar doses of lithium. Additionally there was
no significant difference in the number or the dose of oth-
er psychotropics (including benzodiazepines and ha-
loperidol) among the patients. Pregnant women were
excluded from the study. All participating subjects signed
written informed consents prior to entering the study. Pa-
tients who fulfilled criteria for entry into the study were re-
assessed for diagnosis of bipolar disorder according to
DSM IV criteria. The study protocol was approved by the
Institutional Review Board.
Sampling
Blood samples for lithium determination were taken at 9
a.m. (12 ± 1 hours after the last dose), since lithium ratio
and plasma lithium concentration change only minimally
after this interval [9].
Data collection
Data regarding age of patients, number of hospital admis-
sion for psychiatric reasons, lithium dose, duration of
lithium therapy, PLC, ELC, LR, family history for affective
disorder, and sex are shown in table 1.
Thyroid evaluation
The thyroid size was evaluated by an experienced endo-
crinologist through palpation. Thyroid function tests
(TFT) consisted of T3RU, TT4, FT3, and TSH determined
by radioimmunoassay.
Assay of Lithium
The concentration of intracellular lithium was determined
according to the direct method of Summerton [10]. Twice
distilled water was added to the solutions of plasma and
erythrocyte and the mixture was placed in the graphite fur-
nace (GBC 932 AA, Australia). Conditions used by De-
costerd et al were applied to provide reproducible results
with acceptable sensitivity and accuracy [11]. Samples of
RBC and plasma obtained from patients who were not
treated with lithium were used for calibration, processed
in a similar fashion and stored the same at -70°C. The lat-
ter samples were used to establish calibration curves and
served as internal quality control samples during the as-
say. They were also analyzed whenever intra-assay varia-
tions were doubted and on the beginning of every
working days. The instrument was allowed to warm up at
least 30 minutes before each daily run.
All measurements were repeated twice to detect variability
associated with the procedure.
Statistical analysis
Statistical analyses were performed using SPSS® for Win-
dows™, release 10.0. Data were analyzed using unpaired
student t-test and Fisher's exact test. A logistic regression
analysis was performed to find out any relationship be-
tween covariates and the probability of thyroid abnormal-BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/4
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ity occurrence. A 95% confidence limit was used as
significance level.
Results
Sixty-eight patients with bipolar mood disorder (25 fe-
males, and 43 males with the mean age of 34 ± 11) en-
tered the study. Fourteen patients were assigned to the
group with abnormal thyroid function or/and size. The
rate of each thyroid abnormality is demonstrated in figure
1.
The result of t-test analysis showed a significant decrease
in the LR among patients with thyroid abnormality com-
pared with those who had normal thyroid (table 1). Be-
cause data about duration of lithium therapy was not
complete and reliable, therefore, it was omitted from the
last analysis. Eligible variables (sex, FH, ELC, and LR) were
selected for logistic regression analysis (p < 0.1). Sixty-one
cases were included in the analysis. Thyroid abnormalities
in females were 5.9 times as much as that in males (OR =
5.89, 95% CI = 1.57~22.00). There were no significant dif-
ferences between the two groups with respect to FH, ELC,
and LR in the ultimate analysis.
Discussion
When t-test was used to analyze the data, our study noted
that patients with abnormal thyroid had lower LRs. How-
ever this was not confirmed in the final analysis when lo-
gistic regression model was used.
Inconsistencies were observed among different groups re-
garding the relationship between lithium side effects and
LR.
There are reports of higher LRs in patients with lithium
side effects [12,13]. In contrast, other reports show a high-
er LRs in those without lithium side effects [14,15]. Kamp
did not find any correlation between the concentration of
lithium in erythrocytes and the side effects of lithium
[16].
With regard to thyroid function Rybakowski et al reported
higher activity of lithium sodium counter-transport (LSC)
in patients with higher TSH from a group of lithium-treat-
ed bipolar patients [17]. In the whole group and in female
patients LSC was negatively correlated with LR [17].
Johnston et al found lower LRs in patients with side effects
including hypothyroidism [14].
Discrepancies observed may be due to different methods
of assay used, different designs of studies, definitions of
thyroid disorder, and methods of patient selection. In this
study, a direct method of lithium determination in eryth-
rocytes was used. This method is much more accurate and
less variable compared to the indirect method of lithium
determination [15]. It has been observed that LR is differ-
ent in various types of psychiatric disorders [18–20]; LR
may also differ during episode and during maintenance
therapy [21–23]. It should be noted that our study only
included hospitalized bipolar patients, however other
studies included patients in different stages of the bipolar
disorder or patients with other types of psychiatric diseas-
Table 1: Comparing variables in normal thyroid with abnormal thyroid group.
Variables Normal thyroid group Abnormal thyroid group p value
Age(yra) 33.78 ± 10.62 35.62 ± 12.86 p > 0.05
Admissionb (n) 3.64 ± 3.40 3.30 ± 2.42 p > 0.05
Lithium carbonate dose (mg/d) 1114 ± 263 1157 ± 189 p > 0.05
Durationc 8.31 ± 8.34 13.35 ± 11.84 p = 0.188
PLCd (mmol/l) 0.50 ± 0.24 0.47 ± 0.19 p > 0.05
ELCe (mmol/l) 0.24 ± 0.17 0.15 ± 0.10 p = 0.021
LRf 0.51 ± 0.26 0.34 ± 0.18 p = 0.029
FHh +2 1 +3p  =  0 . 0 3 7
-2 5 -1 1
Sex Female 15 Female 10 p = 0.005
Male 38 Male 4
Plus-minus values are means ± SD a-yr = year b-admission = number of hospital admission for psychiatric problems c-Duration =Length of lithium 
therapy d-PLC = Plasma Lithium Concentration e-ELC = Erythrocyte Lithium Concentration f-LR = ELC/PLC h-FH = Family history of affective dis-
order in first degree relativesBMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/4
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es. [12,13,16]. Among potential sources of discrepancies
regarding LR and side effects, possible ethnic differences
may exist as reported by Strickland et al [24].
The conflicting results might also be partially due to dif-
ferent methods of analysis applied. Absence of significant
difference between PLCs in the two groups demonstrates
its inability to detect lithium-induced thyroid side effects.
Unless all the factors that govern the concentration of lith-
ium in RBC are introduced, it remains unclear whether or
not LR could be used as a diagnostic tool or as a predictor
for developing lithium-induced thyroid disorders.
Although Perrild et al reported no gender difference with
regard to goiter and thyroid volume [25], several investi-
gators showed higher incidences of lithium-induced thy-
roid abnormalities in women [26–29] which is in
agreement with our findings. For instance, Johnston and
Eagles reported a higher prevalence of clinical hypothy-
roidism in women [30].
Bocchetta et al reported female gender and presence of
thyroid autoimmunity as risk factors for developing lithi-
um-induced thyroid abnormalities in a cohort study [31].
Environmental (iodine deficiency) or intrinsic (autoim-
munity) risk factors may inhibit compensatory mecha-
nisms that operate in most patients and lead to thyroid
dysfunction [31].
Probably, iodine deficiency does not play a significant
role in thyroid abnormalities in Iran due to universal salt
iodization since 1989 [32]. According to the report of
Heydarian et al who conducted Tehran Thyroid Study, the
frequencies of AbTPO+ and AbTG+ (antithyroid antibod-
Figure 1
Rate of thyroid abnormalities in the study.
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ies) were 15.9% in women versus 8.3% in men (p <
0.001) and 21.5% in women versus 11% in men (p <
0.001), respectively [33]. The higher rate of thyroid abnor-
malities in females observed in this study may be due to
the autoimmunity effects.
Conclusions
This study showed that LR could not be used as an indica-
tor or a diagnostic tool for thyroid abnormalities. We sug-
gest that monitoring thyroid size and function should
take into account patient's gender, since being a female
may be a risk factor to develop lithium-induced thyroid
abnormalities. Further studies are needed to confirm our
findings.
Authors' contributions
SAAB carried out the psychological assessment and pa-
tient selection , PG participated in its coordination and
manuscript performance (main supervisor), FF participat-
ed in most part of the study as a PhD student for PhD the-
sis (main performer), FE carried out thyroid function
assessment, HF supervised the instrumental analysis, ARD
designed the study (main supervisor), IJ assisted in instru-
mental analysis, ZNH performed the statistical analysis,
SD participated in lithium level determination. All au-
thors read and approved the final manuscript.
Acknowledgements
The assistance of Dr. Nima Naderi, Dr. Monir-Abbasi, Dr. Salamzadeh, Dr. 
Bolourchian, and Mr. Ahadpour is highly acknowledged.
References
1. Kleiner J, Altshuler L, Hendrick V and Hershman JM Lithium-in-
duced subclinical hypothyroidism: Review of the literature
and guideline for treatment J Clin Psychiatry 1999, 60(4):249-255
2. Bagchi N, Brown TR and Mack RE Studies of the mechanism of
inhibition of thyroid function by lithium Biochim Biophys Acta
1978, 542:169
3. Berens SC, Bernstein RS, Robbins J and Wolff J Antithyroid effects
of lithium J Clin Invest 1970, 49:1357
4. Burrow GN, Burke WR and Himmelhoch JM Effects of lithium on
thyroid function J Clin Endocrinol Metab 1971, 32:647
5. Spaulding SW, Burrow GN, Bermudez F and Himmelhoch JM The in-
hibitory effect of lithium on thyroid hormone release in both
euthyroid and thyrotoxic patients J Clin Endocrinol 1972, 35:905
6. Rybakowski JK Lithium in erythrocyte: Pathogenetic and clin-
ical significance Lithium 1990, 1:75-85
7. Elizur A, Shopsin B, Gershon S and Ehlenberger A Intra: extracel-
lular lithium ratios and clinical course in affective states Clin-
ical Pharmacology and Therapeutics 1972, 18:947-952
8. Zakowska-Dabrowska T and Rybakowski J Lithium-induced EEG
changes: Relation to lithium levels in serum and red blood
cells Acta Psychiatrica Scandinavica 1973, 49:457-465
9. Lee CR, Hill SE, Dimitrakoudi M, Jenner FA and Pollitt RJ The rela-
tionship of plasma to erythrocyte lithium levels in patients
taking lithium carbonate Br J Psychiatry 1975, 127:296-298
10. Summerton AM, Harvey NS and Forrest RW New direct method
for measuring red cell lithium J Clin Pathol 1989, 42:435-437
11. Decosterd LA, Buclin T, Dafflon M, Leeman C, Belaz N, Magnin JL and
Biollaz J Determination of trace lithium in human erythro-
cytes by electro-thermal atomic absorption spectrometry
with pyrocoated graphite tubes and integrated platform J
Pharm Pharmacol 1998, 50:693-701
12. Elizur A, Yeret A, Segal Z and Graff E Lithium and electrolytes
plasma RBC ratio and paradoxical lithium neurotoxicity Prog
Neuropsychopharmacol Biol Psychiatry 1982, 6:235-241
13. De Maio D, Buffa G, Riva M, Laviani M and Levi-Minzi A Lithium ra-
tio, phospholipids and the incidence of side effects Prog Neu-
ropsychopharmacol Biol Psychiatry 1994, 18:285-293
14. Johnston BB, Dick EG, Naylor GJ and Dick DAT Lithium side ef-
fects in a routine lithium clinic Brit J Psychiat 1979, 134:482-487
15. Dehpour AR, Emamian ES, Ahmadi-Abhari SA and Azizabadi-Farahani
M The lithium ratio and the incidence of side effects Prog Neu-
ropsychopharmacol Biol Psychiatry 1998, 22:959-970
16. Kamp Johnnis S, Oey Mirjam S, Leijnseybema Henry J, Most Eric VD
and Van Dort-Starn Yvonne The lithium index in a one-year
follow-up Prog Neuropsychopharmacol & Biol Psychiatry 1995, 19:47-57
17. Rybakowski JK, Amsterdom JD, Dyson WL, Frazer A, Winokur A and
Kurtz J Factors contributing to erythrocyte lithium-sodium
counter-transport activity in lithium-treated bipolar
patients Pharmacopsychiatry 1989, 22(1):16-20
18. Rybakowski J, Frazer A, Mendels J and Ramsey TA Erythrocyte ac-
cumulation of lithium ion in control subjects and patients
with primary affective disorder Communi Psychopharmacol 1978,
2:99-104
19. Szentisvanyi I and Janka Z Correlation between the lithium ratio
and Na- dependant lithium transport red blood cells during
lithium prophylaxis Biol Psychiat 1979, 14:973-977
20. Rihmer Z, Arato M, Szentistvanyi I and Banki CM Red blood cell/
plasma lithium ratio in manic depressive, schizoaffective and
schizophrenic patients Psychiatry Clin Basel 1983, 16:405-410
21. Kim YB, Dunner DL, Meltzer HL and Fieve RR Lithium erythro-
cyte: plasma ratio in primary affective disorder Comp Psychiat
1978, 19:129-134
22. Elizur A and Treves I Interdependency of lithium ratio, plasma
lithium level and clinical state in patients with affective
disorder Prog Neuropsychopharmacol & Biol Psychiat 1985, 9:167-172
23. Rybakowski J Lithium in erythrocytes: Pathogenetic and clini-
cal significance Lithium 1990, 1:75-85
24. Strickland TL, Lin KM, Fu P, Anderson D and Zheng Y Comparison
of lithium ratio between African-American and Caucasian
bipolar patients Biol Psychiatry 1995, 37:325-330
25. Perrild H, Hegedus L, Baastrup PC, Kayser L and Kestberg S Thyroid
function and ultrasonically determined thyroid size in pa-
tients receiving long-term lithium treatment Am J Psychiatry
1990, 147(11):1518-1521
26. Cowdry R, Wehr T, Zis A and Goodwin F Thyroid abnormalities
associated with rapid cycling bipolar illness Arch Gen Psychiatry
1983, 40:414-420
27. Yassa R, Saundes A, Nastase C and Camille Y Lithium-induced thy-
roid disorders: A prevalence study J Clin Psychiatry 1988, 49:14-
16
28. Maarbjerg K, Vestergaard P and Schou M Changes in serum thy-
roxin (T4) and serum thyroid stimulating hormone (TSH)
during prolonged lithium treatment Acta Psychiatr Scand 1987,
75:217-221
29. Vincent A, Baruch P and Vincent P Early onset of lithium associ-
ated hypothyroidism J Psychiatry Neurosci 1993, 18:74-77
30. Johnston AM and Eagles JM Lithium-associated clinical
hypothyroidism Br J psychiatry 1999, 175:336-339
31. Bocchetta A, Mossa P, Velluzzi F, Mariotti S, Del Zompo M and Lo-
viselli A Ten-year follow up of thyroid function in lithium
patients J Clin Psychopharmacol 2001, 21(6):594-598
32. Azizi F, Sheikholeslam R, Hedayati M, Mirmiran P, Malekafzali H, Kim-
iagar M and Pajouhi M Sustaineable control of iodine deficiency
in Iran: Beneficial results of the implementation of the man-
datory law on salt iodization J Endocrinol Invest 2002, 25:409-413
33. Heydarian P, Mehrabi Y and Azizi F Tehran Thyroid Study: au-
toimmune thyroid disorders 10 years after implementation
of universal salt iodization. [abstract] J Endocrinol Invest 2002,
25:s92
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-244X/3/4/prepub